H19 in normal development and neoplasia

Molecular Reproduction and Development

Volumn 46, Issue 3, 1997, Pages 419-439

  Looijenga, Leendert H J ^a   Verkerk, Annemieke J M H ^a   De Groot, Nathan ^b   Hochberg, Abraham A ^b   Oosterhuis, J Wolter ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MATURATION; CONGENITAL MALFORMATION; DNA METHYLATION; EMBRYO DEVELOPMENT; GENE EXPRESSION REGULATION; GENE ISOLATION; GENOME IMPRINTING; HUMAN; INHERITANCE; MALIGNANT TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; GERMINOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MUSCLE PROTEINS; NEOPLASMS; PEDIGREE; RNA, UNTRANSLATED; TESTICULAR NEOPLASMS;

EID: 0031019082     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2795(199703)46:3<419::AID-MRD22>3.0.CO;2-S     Document Type: Review

References (251)

1. Adam GIR, Cui HM, Miller SJ, Flam F, Ohlsson R (1996): Allele-specific in situ hybridization (ASISH) analysis: A novel technique which resolves differential allelic usage of H19 within the same cell lineage during human placental development. Development 122:839-847.
2. Allen ND, Barton SC, Hilton K, Norris ML, Surani MA (1994): A functional analysis of imprinting in parthenogenetic embryonic stem cells. Development 120:1473-1482.
3. Andrews PW (1983): The characteristics of cell lines derived from human germ cell tumours. In Damjanov I, Knowles BB, Solter D (eds): "The Biology of Human Teratomas." Chiton: The Human Press, pp. 285-303.
4. Andrews PW (1984): Pluripotent embryonal carcinoma clones derived from the human teratoma cell line Tera-2: Differentiation in vivo and in vitro. Lab Invest 50:147-167.
5. Ariel I, Lustig O, Oyer CE, Elkin M, Gonik B, Rachmilewitz J, Biran H, Goshen R, de Groot N, Hochberg A (1994): Relaxation of imprinting in trophoblastic disease. Gynecol Oncol 53:212-219.
6. Ariel I, Lustig O, Schneider T, Pizov G, Sappir M, de Groot N, Hochberg A (1995a): The imprinted H19 gene as a tumor marker in bladder carcinoma. Urology 45:335-338.
7. Ariel M, Robinson E, McCarrey JR, Cedar H (1995b): Gamete-specific methylation correlates with imprinting of the murine Xist gene. Nature 9:312-315.
8. Arima T (1994): Genetic origin of malignant trophoblastic neoplasms. Cancer Genet Cytogenet 73:95-102.
9. Asherson P, Walsh C, Williams J, Sargeant M, Taylor C, Clements A, Gill M, Owen M, McGuffin P (1994): Imprinting and anticipation: Are they relevant to genetic studies of schizophrenia? Brit J Psych 164:619-624.
10. Banerjee S, Smallwood A (1995): A chromatin model of IFG2/H19 imprinting. Nature Genet 11:237-238.
11. Barlow DP (1993): Methylation and imprinting: From host defence to gene regulation? Science 260:309-310.
12. Barlow DP (1994): Imprinting: A gamete's point of view. Trends Genet 10:194-199.
13. Barlow DP (1995): Gametic imprinting in mammals. Science 270:1610-1613.
14. Barlow DP, Stöger R, Herrmenn BG, Saito K, Schweifer N (1991): The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349:84-87.
15. Bartolomei MS, Zemel S, Tilghman SM (1991): Parental imprinting of the mouse H19 gene. Nature 351:153-155.
16. Bartolomei MS, Webber AL, Brunkow ME, Tilghman SM (1993): Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev 7:1663-1673.
17. Bender R, Surani MA, Kothary R, Li LL, Fuerst DO, Christ B, Fundele R (1995): Tissue specific loss of proliferative capacity of parthenogenetic cells in fetal mouse chimeras. Roux Arch Developm Biol 204:436-443.
18. Bestor TH, Coxon A (1993): Cytosine methylation: The pros and cons of DNA methylation. Curr Biol 3:384-386.
19. Biran H, Ariel I, de Groot N, Shani A, Hochberg A (1994): Human imprinted genes as oncodevelopmental markers. Tumor Biol 15:123-134.
20. Bird A (1992): The essentials of DNA methylation. Cell 70:5-8.
21. Blythe NL, Senior PV, Beck F (1996): Expression of insulin-like growth factor II (IGF-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells. J Anat 188:65-74.
22. Boyes J, Bird A (1991): DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123-1134.
23. Brandeis M, Kafri T, Ariel M, Chaillet JR, McCarrey J, Razin A, Cedar H (1993): The ontogeney of allele-specific methylation associated with imprinted genes in the mouse. EMBO J 12:3669-3677.
24. Brannan CI, Dees EC, Ingram RS, Tighhman SM (1990): The product of the H19 gene may function as an RNA. Molec Cell Biol 10:28-36.
25. Bredael JJ, Vugrin D, Whitmore WF Jr (1982): Autopsy findings in 154 patients with germ cell tumors of the testis. Cancer 50:548-551.
26. Brenton JD, Viville S, Surani MA (1995): Genomic imprinting and cancer. Cancer Surv 25:161-171.
27. Brown KW, Gardner A, Williams JC, Mott MG, McDermott A, Maitland NJ (1992): Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome: A new case and review of the literature. Cancer Genet Cytogenet 58:66-70.
28. Brunkow ME, Tilghman SM (1991): Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev 5:1092-1101.
29. Burke AP, Mostofi FK (1993): Spermatocytic seminoma: A clinicopathologic study of 79 cases. J Urol Pathol 1:21-32.
30. Caron H, Van Sluis P, Van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R (1993): Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4:187-190.
31. Caron H, Peter M, Van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O, Versteeg R (1995): Evidence for two tumour suppressor loci on chromosome bands 1p35-36 involved in neuroblastoma: One probably imprinted, another associated with N-myc amplification. Hum Molec Genet 4:535-539.
32. Cattanach BM, Burtenshaw MD, Rasberry C, Evans EP (1993): Large deletions and other gross forms of chromosome imbalance compatible with viability and fertility in the mouse. Nature Genet 3:56-61.
33. Chaillet JR, Vogt TF, Beier DR, Leder P (1991): Parental-specific methylation of an imprinted transgene is established during gametogenesis and progressively changes during embryogenesis. Cell 66:77-83.
34. Chatkupt S, Lucek PR, Koenigsberger MR, Johnson WG (1992): Parental sex effect in spina bifida: A role for genomic imprinting? Am J Med Genet 44:508-512.
35. Chatkupt S, Antonowicz M, Johnson WG (1995): Parents do matter: Genomic imprinting and parental sex differences in neurological disorders. J Neurol Sci 130:1-10.
36. Chevassu M (1906): "Tumeurs du Testicle." Paris: G. Steinhall.
37. Chung W-Y, Yuan L, Feng L, Hensle T, Tycko B (1996): Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Molec Genet 5:1101-1108.
38. Clemson CM, McNeil JA, Willard HF, Lawrence JB (1996): XIST RNA paints the inactive X chromosome at interphase: Evidence for a novel RNA involved in nuclear chromosome structure. J Cell Biol 132:259-275.
39. Costello CC, Decosse JJ (1992): Possible genomic imprinting in familial adenomatous polyposis [letter]. Lancet 340:918.
40. Crespi MD, Jurkevitch E, Poiret M, d'Aubenton-Carafa Y, Petrovis G, Kondorosi E, Kondorosi A (1994): enod40, a gene expressed during nodule organogenesis, codes for a non-translatable RNA involved in plant growth. EMBO J 13:5099-5112.
41. Cummings OW, Ulbright TM, Eble JN, Roth LM (1994): Spermatocytic seminoma: An immunohistochemical study. Hum Pathol 25:54-59.
42. Davies SJ, Hughes HE (1993): Imprinting in Albright's hereditary osteodystrophy. J Med Genet 30:101-103.
43. Davis RL, Weintraub H, Lassar AB (1987): Expression of a single transfection cDNA converts fibroblast to myoblast. Cell 51:987-1000.
44. De Graaff WE, Oosterhuis JW, De Jong B, Dam A, Van Putten WLJ, Castedo SMMJ, Sleijfer DT, Schraffordt Koops H (1992): Ploidy of testicular carcinoma in situ. Lab Invest 66:166-168.
45. De Groot N, Hochberg A (1993): Gene imprinting during placental and embryonic development. Mol Reprod Developm 36:390-406.
46. De Groot N, Goshen R, Rachmilewitz J, Gonik B, Ben-Hur H, Hochberg A (1993): Genomic imprinting and β-chorionic gonadotropin. Prenatal Diagn 13:1159-1160.
47. De Jong B, Oosterhuis JW, Castedo SMMJ, Vos A, Te Meerman GJ (1990): Pathogenesis of adult testicular germ cell tumors: A cytogenetic model. Cancer Genet Cytogenet 48:143-167.
48. Deal CL (1995): Parental genomic imprinting. Curr Opin Pediatr 7:445-458.
49. DeChiara TM, Robertson EJ, Efstratiadis A (1991): Parental imprinting of the mouse insuline-like growth factor II gene. Cell 64:849-859.
50. Deltour L, Montagutelli X, Guenet JL, Jami J, Paldi A (1995): Tissue- and developmental stage-specific imprinting of the mouse proinsulin gene Ins2. Developm Biol 168:686-688.
51. Dobrovic A, O'Keefe D, Sage RE, Batchelder E (1993): Imprinting and loss of ABO antigens in leukemia. Blood 82:1684-1685.
52. Douc-Rasy S, Coll J, Barrois M, Joubel A, Prost S, Dozier C, Stehelin D, Riou G (1993): Expression of the human fetal BAC/H19 gene in invasive cancers. Int J Oncol 2:753-758.
53. Douc-Rasy S, Barrois M, Fogel S, Ahomadegbe JC, Stehelin D, Coll J, Riou G (1996): High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene 12:423-430.
54. Dubricella T, Anderson D, Aalberg J, DeWolf WC (1982): Cell surface polarization, tight junctions, and eccentric inner cells characterize human teratocarcinoma embryoid bodies. Developm Biol 94:197-205.
55. Dugimont T, Curgy J-J, Wernert N, Delobelle A, Raes M-B, Joubel A, Stehelin D, Coll J (1995): The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas. Molec Cell 85:117-124.
56. Eble JN (1994): Spermatocytic seminoma. Hum Pathol 25:1035-1042.
57. Eden S, Cedar H (1994): Role of DNA methylation in the regulation of transcription. Curr Opin Genet Develop 4:255-259.
58. Efstratiadis A (1994): Parental imprinting of autosomal mammalian genes. Curr Opin Genet Developm 4:265-280.
59. Ekström TJ, Cui H, Li X, Ohlsson R (1995a): Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 121:309-316.
60. Ekström TJ, Cui H, Nyström A, Rutanen EM, Ohlsson R (1995b): Monoallelic expression of IGF2 at the human fetal/maternal boundary. Molec Reprod Devel 41:177-183.
61. Elkin M, Shevelev A, Schulze E, Tyckocinsky M, Cooper M, Ariel I, Pode D, Kopf E, de Groot N, Hochberg A (1995): The expression of the imprinted H19 and IGF-2 genes in human bladder carcinoma. FEBS Letters 374:57-61.
62. Eversole-Cire P, Ferguson-Smith AC, Sadaki H, Brown KD, Cattanach BM, Gonzales FA, Surani MA, Jones PA (1993): Activation of an imprinted Igf2 gene in mouse somatic cell cultures. Molec Cell Biol 13:4928-4938.
63. Eversole-Cire P, Ferguson-Smith AC, Surani MA, Jones PA (1995): Coordinate regulation of igf-2 and H19 in cultured cells. Cell Growth Diff 6:337-345.
64. Ewing J (1911): Teratoma testis and its derivates. Surg Gynecol Obstet 12:230.
65. Farrer LA, Cupples LA, Connor L, Wolf PA, Growdon JH (1991): Association of decreased paternal age and late-onset Alzheimer's disease: An example of genetic imprinting? Arch Neurol 48:599-604.
66. Feil R, Walter J, Allen ND, Reik W (1994): Developmental control of allelic methylation in the imprinted mouse igf2 and H19 genes. Development 120:2933-2943.
67. Feinberg AP (1993): Genomic imprinting and gene activation in cancer. Nature Genet 4:110-113.
68. Feinberg AP, Rainier S, DeBaun MR (1995): Genomic imprinting, DNA methylation, and cancer. Monogr Natl Cancer Inst 17:21-26.
69. Ferguson-Smith AC, Cattanach BM, Barton SC, Beechey CV, Surani MA (1991): Embryological and molecular investigations of parental imprinting on mouse chromosome 7. Nature 351:667-670.
70. Ferguson-Smith AC, Sasaki H, Cattanach BM, Surani MA (1993): Parental-origin-specific epigenetic modification of the mouse H19 gene. Nature 362:751-754.
71. Fogel M, Lifschitz-Mercer B, Moll R, Kushnir I, Jacob N, Waldherr R, Livoff A, Franke WW, Czernobilsky B (1990): Heterogeneity of intermediate filament expression in human testicular seminomas. Differentiation 45:242-249.
72. Franklin GC, Adam GIR, Ohlsson R (1996): Genomic imprinting and mammalian development. Placenta 17:3-14.
73. Friedman NB (1951): The comparative morphogenesis of extragenital and gonadal teratoid tumors. Cancer 4:265-276.
74. Fundele R, Howlett SK, Kothary R, Norris ML, Mills WE, Surani MA (1991): Developmental potential of parthenogenetic cells: Role of genotype-specific modifiers. Development 113:941-946.
75. Fundele RH, Surani MA (1994): Experimental embryological analysis of genetic imprinting in mouse development. Develop Genet 15:515-522.
76. Fundele R, Barton SC, Christ B, Krause R, Surani MA (1995a): Distribution of androgenetic cells in fetal mouse chimeras. Roux Arch Developm Biol 204:484-493.
77. Fundele R, Li LL, Herzfeld A, Barton SC, Surani MA (1995b): Proliferation and differentiation of androgenetic cells in fetal mouse chimeras. Roux's Arch Developm Biol 204:494-501.
78. Furtado S, Suchowersky O (1994): Investigation of the potential role of genetic imprinting in Gilles de la Tourette syndrome. Am J Med Genet 51:51-54.
79. Giannoukakis N, Deal C, Paquette J, Kukuvitis A, Polychronakos C (1996): Polymorphic functional imprinting of the human IGF2 gene among individuals, in blood cells, is associated with H19 expression. Biochem Biophys Res Commun 220:1014-1019.
80. Giddings SJ, King CD, Harman KW, Flood JF, Carnaghi LR (1994): Allele specific inactivation of insulin 1 and 2, in the mouse yolk sac, indicates imprinting. Nature Genet 6:310-313.
81. Glenn CC, Porter KA, Jong MTC, Nicholls RD, Driscoll DJ (1993): Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Molec Genet 2:2001-2005.
82. Goshen R, Rachmilewitz J, Schneider T, de Groot N, Ariel I, Palti Z, Hochberg AA (1993): The expression of the H19 and IGF2 genes during human embryogenesis and placental development. Mol Reprod Devel 34:374-379.
83. Grigoroiu-Serbanescu M, Nothen M, Propping P, Poustka F (1995): Clinical evidence for genomic imprinting in bipolar I disorder. Acta Psychiatr Scand 92:365.
84. Guillemot F, Nagy A, Auerbach A, Rossant J, Joyner AL (1994): Essential role of Mash-2 in extraembryonal development. Nature 371:333-336.
85. Guillemot F, Caspary T, Tighman SM, Copeland NG, Gilbert DJ, Jenkins NA, Anderson DJ, Joyner AL, Rossant J, Nagy A (1995): Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nature Genet 9:235-241.
86. Haas OA, Argyriou-Tirita A, Lion T (1992): Parental origin of chromosomes involved in the translocation t(9;22). Nature 359:414-416.
87. Haig D (1993): Genomic imprinting, human chorionic gonadotropin, and triploidy [letter]. Prenat Diagn 13:151.
88. Haig D (1994): Is human insulin imprinted? Nature Genetics 7:10.
89. Hall JG (1990): Genomic imprinting: Review and relevance to human diseases. Am J Hum Genet 46:857-873.
90. Han DKM, Liau G (1992): Identification and characterization of developmentally regulated genes in vascular smooth muscle cells. Circ Res 71:711-719.
91. Han DKM, Khaing ZZ, Pollock RA, Haudenschild CC, Liau G (1996): H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest 97:1276-1285.
92. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993): Tumour-suppressor activity of H19 RNA. Nature 365:764-767.
93. Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, Kimura T, Tokugawa Y, Kanai T, Saji F (1995): Loss of imprinting in choriocarcinoma. Nature Genet 9:109-110.
94. kip2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet 11:204-206.
95. Hatada I, Sugama T, Mukai T (1993): A new imprinted gene cloned by a methylation-sensitive genome scanning method. Nucl Acid Res 21:5577-5582.
96. KIP2 and its reduced expression in Wilms' tumors. Hum Molec Genet 5:783-788.
97. Hayashizaki Y, Shibata H, Hirotsune S, Sugino H, Okazaki Y, Sasaki N, Hirose K, Imoto H, Okuizumi H, Muramatsu M, Komatsubara H, Shiroishi T, Moriwaki K, Katsuki M, Hatano N, Sasaki H, Ueda T, Mise N, Takagi N, Plass C, Chapman VM (1994): Identification of an imprinted U2af binding protein related sequence on mouse chromosome 11 using the RLGS method. Nature Genet 6:33-39.
98. Hergersberg M (1991): Biological aspects of cytosine methylation in eukaryotic cells. Experientia 47:1171-1185.
99. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K, Takagi H (1996): Loss of H19 imprinting in esophageal cancer. Cancer Res 56:480-482.
100. Hurst LD, McVean G, Moore T (1996): Imprinted genes have few and small introns. Nature Genet 12:234-237.
101. Jinno Y, Yun K, Nishiwaki K, Kubota T, Ogawa O, Reeve AE, Niikawa N (1994): Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet 6:305-309.
102. Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda T, Inuzuka K, Fujishita A, Ohtani Y, Okimoto T, Ishimaru T, Niikawa N (1995): Establishment of functional imprinting of the H19 gene in human developing placentae. Nature Genet 10:318-331.
103. Jinno Y, Sengoku K, Nakao M, Tamate K, Miyamoto T, Matsuzaka T, Sutcliffe JS, Anan T, Takuma N, Nishiwaki K, Ikeda Y, Ishimaru T, Ishikawa M, Niikawa N (1996): Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum Molec Genet 5:1155-1161.
104. John RM, Surani MA (1996): Imprinted genes and regulation of gene expression by epigenetic inheritance. Curr Opin Cell Biol 8:348-353.
105. Johnson DE, Appelt G, Samuels ML, Luna M (1976): Metastases from testicular carcinoma. Urology 8:234-239.
106. Junien C (1992): Beckwith-Wiedemann syndrome, tumourigenesis and imprinting. Curr Opin Genet Developm 2:431-438.
107. Jørgensen N, Rajpert-De Meyts E, Graem N, Mueller J, Giwercman A, Skakkebæk NE (1995): Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 72:223-231.
108. Kanbour-Shakir A, Kunz HW, Gill TJ (1993): Differential genomic imprinting of major histocompatibility complex class I antigens in the placenta of the rat. Biol Reprod 48:977-986.
109. Kaneko-Isshino T, Kuroiwa Y, Miyoshi N, Kohda T, Suzuki R, Yokoyama M, Viville S, Barton SC, Ishino F, Surani MA (1995): Peg1/Mest imprinted gene on chromosome 6 identified by cDNA subtraction hybridization. Nat Genet 11:52-59.
110. Kay GF, Barton SC, Surani MA, Rastan S (1994): Imprinting and X chromosome counting mechanisms determine Xist expression in early mouse development. Cell 77:639-650.
111. Kitsberg D, Selig S, Brandeis M, Simon I, Keshet I, Driscoll DJ, Nicholls RD, Cedar H (1993): Allele-specific replication timing of imprinted gene regions. Nature 364:459-463.
112. Koi M, Johnson LA, Kalikin LM, Little PFR, Nakamura Y, Feinberg AP (1993): Tumor cell growth arrest caused by subchromosomal transfectable DNA fragments form chromosome 11. Science 260:361-364.
113. Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T (1995): Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene 10:1193-1198.
114. KIP2 gene at 11p15.5. Oncogene 12:1365-1368.
115. Kuroiwa Y, Kaneko-Ishino T, Kahitani F, Kohda T, Li LL, Tada M, Suzuki R, Ykoyama M, Shiroishi T, Wakana S, Barton SC, Ishino F, Surani MA (1996): Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nature Genet 12:186-190.
116. LaBuda MC, Fletcher NA, Korczyn AD, Inzelberg R, Harding AE, Pauls DL (1993): Genomic imprinting and anticipation in idiopathic torsion dystonia. Neurology 43:2040-2043.
117. Laird CD (1991): The X-inactivation imprinting model of the fragile-X syndrome: Annotated references, 1990. Prog Clin Biol Res 368:101-110.
118. Langlois S (1994): Genomic imprinting: a new mechanism for disease. Pediatr Pathol 14:161-165.
119. Latham KE (1995): Stage-specific and cell type-specific aspects of genomic imprinting effects in mammals. Development 269-282.
120. Latham KE, Solter D (1991): Effect of egg composition on the developmental capacity of androgenetic mouse embryos. Development 113:561-568.
121. Latham KE, McGrath J, Solter D (1995): Mechanistic and developmental aspects of genetic imprinting in mammals. Int Rev Cytol 160:53-98.
122. Leff SE, Brannan CI, Reed ML, Ozcelik T, Francke U, Copeland NG, Jenkins NA (1993): Maternal imprinting of the mouse Snrpn gene and conserved linkage homology with the human Prader-Willi syndrome region. Nature Genet 2:259-264.
123. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM (1995a): Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375:34-39.
124. Leighton PA, Saam JR, Ingram RS, Stewart CL, Tilghman SM (1995b): An enhancer deletion affects both H19 and Igf2 expression. Genes Developm 9:2079-2089.
125. Leighton PA, Saam JR, Ingram RS, Tilghman SM (1996): Genomic imprinting in mice: its function and mechanism. Biol Reproduc 54:273-278.
126. Li E, Bestor TH, Jaenisch R (1992): Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69:915-926.
127. Li E, Beard C, Jaenisch R (1993): Role of DNA methylation in genomic imprinting. Nature 366:362-365.
128. Li XR, Adam G, Cui HM, Sandstedt B, Ohlsson R, Ekström TJ (1995): Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: Uncoupling of IGF2 and H19 imprinting. Oncogene 11:221-229.
129. Lichter DG, Jackson LA, Schachter M (1995): Clinical evidence of genomic imprinting in Tourette's syndrome. Neurology 45:924-928.
130. Lindor NM, Ney JA, Gaffey TA, Jenkins RB, Thibodeau SN, Dewald GW (1992): A genetic review of complete and partial hydatidiform moles and nonmolar triploidy. Mayo Clin Proc 67:791-799.
131. Looijenga LH, Oosterhuis JW, Ramaekers FC, De Jong B, Dam A, Beck JL, Sleijfer DT, Schraffordt Koops H (1991): Dual parameter flow cytometry for deoxyribonucleic acid and intermediate filament proteins of residual mature teratoma: All tumor cells are aneuploid. Lab Invest 64:113-117.
132. Looijenga LHJ, Abraham M, Gillis AJM, Saunders GF, Oosterhuis JW (1994): Testicular germ cell tumors of adults show deletions of chromosomal bands 11p13 and 11p15.5, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms' tumor 1 gene. Genes Chromosom Cancer 9:153-160.
133. Lorberboum-Galski H, Yarkoni S, Nechushtan A, Rachmilewitz J, De Groot N, Hochberg A (1994): ABL and BCR genes are not imprinted in androgenetic and gynogenetic human tissues. Biochem Biophys Res Commun 204:621-627.
134. Lothe RA, Fosså SD, Stenwig AE, Nakamura Y, White R, Børresen AL, Brøgger A (1989): Loss of 3p or 11p alleles is associated with testicular cancer tumors. Genomics 5:134-138.
135. Lothe RA, Hastie N, Heimdal K, Fosså SD, Stenwig AE, Børresen AL (1993): Frequent loss of 11p13 and 11p15 loci in male germ cell tumours. Genes Chromos Cancer 7:96-101.
136. Lothe RA, Peltomaeki P, Tommerup N, Fosså SD, Stenwig AE, Børresen AL, Nesland JM (1995): Molecular genetic changes in human male germ cell tumors. Lab Invest 73:606-614.
137. Lustig O, Ariel I, Ilan J, Lev-Lehman E, De Groot N, Hochberg A (1994): Expression of the imprinted gene H19 in the human fetus. Molec Reprod Develop 38:239-246.
138. Manivel JC, Niehans G, Wick MR, Dehner LP (1987): Intermediate trophoblast in germ cell neoplasms. Am J Surg Pathol 11(9):693-701.
139. Mann JR, Stewart CL (1991): Development to term of mouse androgenetic aggregation chimeras. Development 113:1325-1333.
140. Mann JR, Gadi I, Harbison ML, Abbondanzo SJ, Stewart CL (1990): Androgenetic mouse embryonic stem cells are pluripotent and cause skeletal defects in chimeras: Implications for genetic imprinting. Cell 62:251-260.
141. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, Coad N, de Pagter-Holthuizen P, Pearson PL (1988): Molecular nature of genetic changes resulting in loss of heyterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81:41-48.
142. Mannens M, Devilee P, Bliek J, Mandjes I, de Kraker J, Heyting C, Slater RM, Westerveld A (1990): Loss of heterozygosity in Wilms' tumors, studied for six putative tumor supressor regions, is limited to chromosome 11. Cancer Res 50:3279-3283.
143. Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, Coad N, Steenman M, Bliek J, Niikawa N, Tonoki H, Nakamura Y, De Boer EG, Slater RM, John R, Cowell JK, Junien C, Henry I, Tommerup N, Weksberg R, Pueschel SM, Leschot NJ, Westerveld A (1994): Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia. Eur J Hum Genet 2:3-23.
144. Matsui Y, Zsebo K, Hogan BL (1992): Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 70:841-847.
145. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Ellegde SJ (1995): p57kip2, a structurally distinct member of the p21cip1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Developm 9:650-662.
146. KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93:3026-3030.
147. McCarthy BJ, Dorman JS, Aston CE (1991): Investigating genomic imprinting and susceptibility to insulin-dependent diabetes mellitus: An epidemiologic approach. Genetic Epidemiology 8:177-186.
148. McFadden DE, Kwong LC, Yam IYL, Langlois S (1993): Parental origin of triploidy in human fetuses: Evidence for genomic imprinting. Hum Genet 92:465-469.
149. McGrew MJ, Rosenthal N (1993): Quantitation of genomic methylation using ligation-mediated PCR. BioTechniques 15:722-729.
150. McKarney LA, Overall ML, Dziadek M (1996): Expression of H19 and Igf2 genes in uniparental mouse ES cells during in vitro and in vivo differentiation. Differentiation 60:75-86.
151. McLaughlin KJ, Szabo P, Haegel H, Mann JR (1996): Mouse embryos with paternal duplication of an imprinted chromosome 7 region die at midgestation and lack placental spongiotrophoblast. Development 122:265-270.
152. Mendel G (1866): Experiments on plants hybrids. In Stern C, Sherwood ER (eds): "The origin of genetics," San Francisco: Freeman, pp 1-48.
153. Moore T, Haig D (1991): Genomic imprinting in mammalian development: A parental tug of war. Trends Genet 7:45-49.
154. Mostofi FK (1984): Tumour markers and pathology of testicular tumours In Progress and controversies in oncological urology New York: Alan R. Liss, pp 69-87.
155. Mostofi FK, Sesterhenn IA, Davis CJJ (1987): Immunopathology of germ cell tumors of the testis. Sem Diagn Pathol 4:320-341.
156. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, Tycko B (1994): Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nature Genet 7:440-447.
157. Mowery-Rushton PA, Driscoll DJ, Nicholls RD, Locker J, Surti U (1996): DNA methylation patterns in human tissues of uniparental origin using a zinc-finger gene (ZNF127) from the Angelman/Prader-Willi region. Am J Med Genet 61:140-146.
158. Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ (1993): Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet 53:1096-1102.
159. Møller H, Jørgenson N, Forman D (1995): Trends in incidence of testicular cancer in boys and adolescent men. Int J Cancer 61:761-764.
160. Nakao M, Sutcliffe JS, Durtschi B, Mutirangura A, Ledbetter DH, Beaudet AL (1994): Imprinting analysis of three genes in the Prader-Willi/Angelman region: SNRPN, E6-associated protein, and PAR-2 (D15S225E). Hum Molec Genet 3:309-315.
161. Neumann B, Kubicka P, Barlow DP (1995): Characteristics of imprinted genes. Nature Genet 9:12-13.
162. Nicholls RD (1993): Genomic imprinting and uniparental disomy in Angelman and Prader-Willi syndromes: A review. Am J Med Genet 46:16-25.
163. Nicholls RD (1994): New insights reveal complex mechanisms involved in genomic imprinting. Am J Hum Genet 54:733-740.
164. O'Brien SJ, Womack JE, Lyons LA, Moore KJ, Jenkins NA, Copeland NG (1993): Anchored reference loci for comparative genome mapping in mammals. Nature Genet 3:103-112.
165. Ogura A, Matsuda J, Yanagimachi R (1994): Birth of normal young after electrofusion of mouse oocytes with round spermatids. Proc Natl Acad Sci USA 91:7460-7482.
166. Ohlsson R, Nyström A, Pfeifer-Ohlsson S, Toehoenen V, Hedborg F, Schofield P, Flam F, Ekström TJ (1993): IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nature Genet 4:94-97.
167. Ohlsson R, Barlow D, Surani A (1994a): Impressions of imprints. Trends Genet 10:415-417.
168. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekström TJ (1994b): Overlapping patterns of IGF2 and H19 expression during human development: Biallelic IGF2 expression correlates with a lack of H19 expression. Development 120:361-368.
169. Oliver RTD (1987): HLA phenotype and clinicopathological behaviour of germ cell tumours: possible evidence for clonal evolution from seminomas to nonseminomas. Int J Androl 10:85-93.
170. Oliver RTD (1990): Clues from natural history and results of treatment supporting the monoclonal origin of germ cell tumours. Cancer Surv 9:333-368.
171. Oosterhuis JW, Castedo SMMJ, De Jong B, Cornelisse CJ, Dam A, Sleijfer DT, Schraffordt Koops H (1989): Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest 60:14-20.
172. Oosterhuis JW, Castedo SMMJ, De Jong B (1990): Cytogenetics, ploidy and differentiation of human testicular, ovarian and extragonadal germ cell tumours. Cancer Surv 9:321-332.
173. Pachnis V, Brannan CI, Tilghman SM (1988): The structure and expression of a novel gene activated in early mouse embryogenesis. EMBO J 7:673-681.
174. Paldi A, Gyapay G, Jami J (1995): Imprinted chromosomal regions of the human genome display sex-specific meiotic recombination frequencies. Current Biol 5:1030-1035.
175. Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, NBewlands E (1996): A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles, and 107 non-molar hydropic abortions. Histopathol 28:101-109.
176. Pedone PV, Cosma MP, Ungaro P, Colantuoni V, Bruni CB, Zarrilli R, Riccio A (1994): Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated. J Biol Chem 269:23970-23975.
177. Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N (1996): Requirement for Xist in X chromosome inactivation. Nature 379:131-137.
178. Pfeifer GP, Steigerwald SD, Mueller PR, Wold B, Riggs AD (1989): Genomic sequencing and methylation analysis by ligation mediated PCR. Science 246:810-813.
179. Pierce GB, Abell MR (1970): Embryonal carcinoma of the testis. Pathol Annu 5:27.
180. Poirier F, Chan CTJ, Timmons PM, Robertson EJ, Evans MJ, Rigby PWJ (1991): The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 113:1105-1114.
181. Pugliese A, Awdeh ZL, Alper CA, Jackson RA, Eisenbarth GS (1994): The paternally inherited insulin gene B allele (1,428 FokI site) confers protection from insulin-dependent diabetes in families. J Autoimmun 7:687-694.
182. Rachmilewitz J, Gileadi O, Eldar-Geva T, Schneider T, De Groot N, Hochberg A (1992a): Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Molec Reprod Develop 32:196-202.
183. Rachmilewitz J, Goshen R, Ariel I, Schneider T, De Groot N, Hochberg A (1992b): Parental imprinting of the human H19 gene. FEBS Lett 309:25-28.
184. Rachmilewitz J, Elkin M, Rosensaft J, Gelman-Kohan Z, Ariel I, Lustig O, Schneider T, Goshen R, Biran H, De Groot N, Hochberg A (1995): H19 expression and tumorigenicity of choriocarcinoma derived cell lines. Oncogene 11:863-870.
185. Rachmilewitz J, Looijenga LHJ, Verkerk AJMH, Gonik B, Werner D, De Groot N, Hochberg A (1996): Activation of the maternal allele of the IPW gene. Oncogene 13:1687-1692.
186. Raghavan D, Heyderman E, Monaghan P, Gibbs J, Ruoslahti E, Peckham MJ, Neville AM (1981): Hypothesis: when is seminoma not a seminoma? J Clin Pathol 34:123-124.
187. Raghavan D, Sullivan AL, Peckham MJ, Neville AM (1982): Elevated serum alphafetoprotein and seminoma. Clinical evidence for a histologic continuum? Cancer 50:982-989.
188. Rainier S, Dobry CJ, Feinberg AP (1995): Loss of imprinting in hepatoblastoma. Cancer Res 55:1836-1838.
189. Rastinejad F, Blau HM (1993): Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell 72:903-917.
190. Razin A, Cedar H (1991): DNA methylation and gene expression. Microbiol Rev 55:451-458.
191. Reed ML, Leff SE (1994): Maternal imprinting of human SNRPN, a gene deleted in Prader-Willi syndrome. Nature Genet 6:163-167.
192. Reid LH, West A, Gioeli DG, Phillips KK, Kelleher KF, Araujo D, Stanbridge EJ, Dowdy SF, Gerhard DS, Weissman BE (1996): Localisation of a tumor suppressor gene in 1p15.5 using the G401 Wilms' tumor assay. Hum Molec Genet 5:239-247.
193. Reik W, Brown KW, Slatter RE, Sartori P, Elliott M, Maher ER (1994): Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome. Hum Molec Genet 3:1297-1301.
194. Reik W, Brown KW, Schneid H, Le Bouc Y, Bickmore W, Maher ER (1995): Imprinting mutations in Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Molec Genet 4:2379-2385.
195. Riesewijk AM, Schepens MT, Welch TR, Van den Berg-Loonen EM, Mariman EM, Ropers HH, Kalscheuer VM (1996): Maternal-specific methylation of the human IGF2R gene is not accompanied by allele-specific transcription. Genomics 31:158-166.
196. Rinke de Wit TF, Wilson L, Van den Elsen PJ, Thielen F, Brekhoff D, Oosterhuis JW, Pera MF, Stern PL (1991): Monoclonal antibodies to human embryonal carcinoma cells: Antigenic relationships of germ cell tumors. Lab Invest 65:180-191.
197. Rossant J (1993): Immortal germ cells? The derivation of permanent pluripotent stem cell lines directly from mouse germ cells in vitro promises to provide a new source of stem cells for genetic manipulation of mammals. Current Biol 3:47-49.
198. Sapienza C (1995): Genome imprinting: an overview. Developm Genet 17:185-187.
199. Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith AC, Barton SC, Reik W, Surani MA (1992a): Parental imprinting: Potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Developm 6:1843-1856.
200. Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith AC, Barton SC, Reik W, Surani MA (1992b): Parental imprinting: potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Developm 6:1843-1856.
201. Sasaki H, Ferguson-Smith AC, Shum ASW, Barton SC, Surani MA (1995): Temporal and spatial regulation of H19 imprinting and uniparental mouse embryos. Development 121:4195-4202.
202. Schroeder WT, Chao LY, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, Saunders GF (1987): Nonrandom loss of maternal chromosome 11 alleles in Wilms tumours. Am J Hum Genet 40:413-420.
203. Scully RE (1979): "Atlas of tumor Pathology," 2nd edition. Washington, DC: Armed Forces Institute of Pathology.
204. Searle AG, Beechey CV (1990): Genomic imprinting of mouse chromosome 7. Genet Res 7:237-244.
205. Shemer R, Birger Y, Dean WL, Reik W, Riggs AD, Razin A (1996): Dynamic methylation adjustment and counting as part of imprinting mechanisms. Proc Natl Acad Sci USA 93:6371-6376.
206. Skakkebæk NE, Berthelsen JG, Giwercman A, Müller J (1987): Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours exept spermatocytoma. Int J Androl 10:19-28.
207. Solter D (1988): Differential imprinting and expression of maternal and paternal genomes. Ann Rev Genet 22:127-146.
208. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994): Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet 7:433-439.
209. Sunde L, Vejerslev LO, Jensen MP, Pedersen S, Hertz JM, Bolund L (1993): Genetic analysis of repeated, biparental, diploid, hydatidiform moles. Cancer Genet Cytogenet 66:16-22.
210. Surani MA (1993): Silence of genes. Nature 366:302-303.
211. Surani MA (1994): Genomic imprinting: Control of gene expression by epigenetic inheritance. Current Opin Cell Biol 6:390-395.
212. Sutcliffe JS, Nakao M, Christian S, Orstavik KH, Tommerup N, Ledbetter DH, Beaudet AL (1994): Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region. Nat Genet 8:52-58.
213. Sved JA, Laird CD (1990): Population genetic consequences of the fragile X-syndrome, based on the X-inactivation imprinting model. Am J Human Genet 46:443-451.
214. Svensson K, Walsh C, Fundele R, Ohlsson R (1995): H19 is imprinted in the choroid plexus and leptomeninges of the mouse foetus. Mech Develop 51:31-37.
215. Szabo PE, Mann JR (1994): Expression and methylation of imprinted genes during in vitro differentiation of mouse parthenogenetic and androgenetic embryonic stem cell lines. Development 120:1651-1660.
216. Szabo PE, Mann JR (1995): Biallelic expression of imprinted genes in the mouse germ line: Implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Developm 9:1857-1868.
217. Taniguchi T, Sullivan MJ, Ogawa O, Reeve AE (1995): Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms tumor. Proc Natl Acad Sci USA 92:2159-2163.
218. Temple IK, James RS, Crolla JA, Sitch FL, Jacobs PA, Howell WM, Betts P (1995): An imprinted gene(s) for diabetes. Nature genet 9:110-112.
219. Temple IK, Gardner RJ, Robinson DO, Kibirige MS, Ferguson AW, Baum JD, Barber JCK, Janes RS, Shield JPH (1996): Further evidence for an imprinted gene for neonatal diabetes localised to chromosome 6q22-23. Hum Molec Genet 5:1117-1121.
220. Thomas JH (1995): Genomic imprinting proposed as a surveillance mechanism for chromosome loss. Proc Natl Acad Sci USA 92:480-482.
221. Tremblay KD, Saam JR, Ingram RS, Tilghman SM, Bartolomei MS (1995): A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nature Genet 9:407-413.
222. Tucker KL, Beard C, Dausman J, Jackson-Grusby L, Laird PW, Lei H, Li E, Jaenisch R (1996): Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Develop 10:1008-1020.
223. Tycko B (1994): Genomic imprinting: Mechanism and role in human pathology. Am J Pathol 144:431-443.
224. Van Echten J, Oosterhuis JW, Looijenga LHJ, Wiersma J, te Meerman G, Schraffordt Koops H, Sleijfer DTh, De Jong B (1995): No recurrent structural abnormalities in germ cell tumors of the adult testis apart from i(12p). Genes Chromosom Cancer 14:133-144 (Abstract).
225. Van der Mey AGL, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, Vd Kamp JJP (1989): Genomic imprinting in heriditary glomus tumours: evidence for new genetic theory. Lancet 1291-1294.
226. Van Gils APG, Van der Mey AGL, Hoogma RPLM, Sandkuijl LA, Maaswinkel-Mooy PD, Falke THM, Pauwels EKJ (1992): MRI screening of kindred at risk of developing paragangliomas: Support for genomic imprinting in hereditary glomus tumours. Brit J Cancer 65:903-907.
227. Van Gurp RJLM, Oosterhuis JW, Kalscheuer V, Mariman ECM, Looijenga LHJ (1994): Human testicular germ cell tumors show biallelic expression of the H19 and IGF2 gene. J Natl Cancer Inst 86:1070-1075.
228. Varmuza S (1993): Gametic imprinting as a speciation mechanism in mammals. J Theor Biol 164:1-13.
229. Verkerk AJMH, Ariel I, Dekker MC, Schneider T, Van Gurp RJLM, de Groot N, Oosterhuis JW, Hochberg AA, Looijenga LHJ (1997): Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene (in press).
230. Villar AJ, Pedersen RA (1994): Parental imprinting of the Mas protooncogene in mouse. Nature Genet 8:373-379.
231. Villar AJ, Eddy EM, Pedersen RA (1995): Developmental regulation of genomic imprinting during gametogenesis. Developm Biol 172:264-271.
232. Viville S, Surani MA (1995): Towards unravelling the igf2/H19 imprinted domain. BioEssays 17:835-838.
233. Voutilainen R, Ilvesmaeki V, Ariel I, Rachmilewitz J, De-Groot N, Hochberg A (1994): Parallel regulation of parentally imprinted H19 and insulin-like growth factor-II genes in cultured human fetal adrenal cells. Endocrinology 134:2051-2056.
234. Wada M, Seeger RC, Mizoguchi H, Koeffler HP (1995): Maintenance of normal imprinting of H19 and IGF2 genes in neuroblastoma. Cancer Res 55:3386-3388.
235. Walsh C, Miller SJ, Flam F, Fisher RA, Ohlsson R (1995): Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res 55:1111-1116.
236. Walsh C, Glaser A, Fundele R, Ferguson-Smith A, Barton S, Surani MA, Ohlsson R (1994): The non-viability of uniparental mouse conceptuses correlates with the loss of the products of imprinted genes. Mech Developm 46:55-62.
237. Walt H, Arrenbrecht S, Delozier-Blanchet CD, Keller PJ, Nauer R, Hedinger CE (1986): A human testicular germ cell tumor with borderline histology between seminoma and embryonal carcinoma secreted beta-human chorionic gonadotropin and alpha-fetoprotein only as a xenograft. Cancer 58:139-146.
238. Weinberg RA (1996): E2F and cell proliferation: a world turned upside down. Cell 85:457-459.
239. Weksberg R, Teshima I, Williams BRG, Greenberg CR, Pueschel SM, Chernos JE, Fowlow SB, Hoyme E, Anderson IJ, Whiteman DAH, Fisher N, Squire J (1993): Molecular characterization of cytogenetic alterations associated with the Beekwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum Molec Genet 2:549-556.
240. Wevrick R, Kerns JA, Francke U (1994): Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum Molec Genet 3:1877-1882.
241. Whitelaw S, Love S, Hodgson S (1992): Familial adenomatous polyposis and genomic imprinting [letter]. Lancet 340:1547.
242. Xu Y, Goodyer CG, Deal C, Polychronakos C (1993): Functional polymorphism in the parental imprinting of the human IGF2R gene. Biochem Biophys Res Comm 197:747-754.
243. Yballe CM, Vu TH, Hoffman AR (1996): Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. J Endocrinol Metabol 81:1607-1612.
244. Yoo-Warren H, Pachnis V, Ingram RS, Tilghman SM (1988): Two regulating domains flank the mouse H19 gene. Molec Cell Biol 8:4707-4715.
245. Zemel S, Bartolomei M, Tilghman S (1992): Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nature Genet 2:61-65.
246. Zerres K, Rudnik-Schoneborn S (1995): On genetic heterogeneity, anticipation, and imprinting in polycystic kidney diseases. Nephrol Dial Transplant 10:7-9.
247. Zhan SL, Shapiro DN, Helman LJ (1995): Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene 11:2503-2507.
248. Zhang Y, Tycko B (1992): Monoallelic expression of the human H19 gene. Nature Genet 1:40-44.
249. Zhang Y, Shields T, Crenshaw T, Hao Y, Moulton T, Tycko B (1993): Imprinting of human H19: Allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet 53:113-124.
250. Zheng CJ, Thomson G, Peng YN (1994): Allelic instability in mitosis can explain "genome imprinting" and other genetic phenomena in psoriasis. Am J Med Genet 51:163-164.
251. Zucotti M, Monk M (1995): Methylation of the mouse Xist gene in sperm and eggs correlates with imprinted Xist expression and paternal X-incativation. Nature 9:316-320.